144 related articles for article (PubMed ID: 8941198)
1. Self-poisoning among adults using multiple transdermal nicotine patches.
Woolf A; Burkhart K; Caraccio T; Litovitz T
J Toxicol Clin Toxicol; 1996; 34(6):691-8. PubMed ID: 8941198
[TBL] [Abstract][Full Text] [Related]
2. Childhood poisoning involving transdermal nicotine patches.
Woolf A; Burkhart K; Caraccio T; Litovitz T
Pediatrics; 1997 May; 99(5):E4. PubMed ID: 9113961
[TBL] [Abstract][Full Text] [Related]
3. Nicotine replacement products: poisoning in children.
Prescrire Int; 2014 May; 23(149):126-8. PubMed ID: 24926513
[TBL] [Abstract][Full Text] [Related]
4. An attempted suicide using transdermal nicotine patches.
Labelle A; Boulay LJ
Can J Psychiatry; 1999 Mar; 44(2):190. PubMed ID: 10097845
[No Abstract] [Full Text] [Related]
5. Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy.
Lawson GM; Hurt RD; Dale LC; Offord KP; Croghan IT; Schroeder DR; Jiang NS
J Clin Pharmacol; 1998 Jun; 38(6):502-9. PubMed ID: 9650539
[TBL] [Abstract][Full Text] [Related]
6. Predictors and timing of adverse experiences during trandsdermal nicotine therapy.
Gourlay SG; Forbes A; Marriner T; McNeil JJ
Drug Saf; 1999 Jun; 20(6):545-55. PubMed ID: 10392670
[TBL] [Abstract][Full Text] [Related]
7. Use of nicotine patches in breast-feeding mothers: transfer of nicotine and cotinine into human milk.
Ilett KF; Hale TW; Page-Sharp M; Kristensen JH; Kohan R; Hackett LP
Clin Pharmacol Ther; 2003 Dec; 74(6):516-24. PubMed ID: 14663454
[TBL] [Abstract][Full Text] [Related]
8. Nicotine-mecamylamine interactions.
Zevin S; Jacob P; Benowitz NL
Clin Pharmacol Ther; 2000 Jul; 68(1):58-66. PubMed ID: 10945316
[TBL] [Abstract][Full Text] [Related]
9. Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment.
Gourlay SG; Benowitz NL; Forbes A; McNeil JJ
Eur J Clin Pharmacol; 1997; 51(5):407-14. PubMed ID: 9049583
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of nicotine and safety of smokers wearing transdermal delivery systems during multiple simultaneous intake of nicotine and during exercise.
Homsy W; Yan K; Houle JM; Besner JG; Gossard D; Pierce CH; Caillé G
J Clin Pharmacol; 1997 Aug; 37(8):728-36. PubMed ID: 9378845
[TBL] [Abstract][Full Text] [Related]
11. Postmortem distribution of nicotine and cotinine from a case involving the simultaneous administration of multiple nicotine transdermal systems.
Kemp PM; Sneed GS; George CE; Distefano RF
J Anal Toxicol; 1997; 21(4):310-3. PubMed ID: 9248951
[TBL] [Abstract][Full Text] [Related]
12. Use of transdermal nicotine systems in a possible suicide attempt.
Montalto N; Brackett CC; Sobol T
J Am Board Fam Pract; 1994; 7(5):417-20. PubMed ID: 7810357
[TBL] [Abstract][Full Text] [Related]
13. Nicotine and metabolites determination in human plasma by ultra performance liquid chromatography-tandem mass spectrometry: a simple approach for solving contamination problem and clinical application.
Liachenko N; Boulamery A; Simon N
Fundam Clin Pharmacol; 2015 Oct; 29(5):499-509. PubMed ID: 26118829
[TBL] [Abstract][Full Text] [Related]
14. Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving.
Selby P; Andriash K; Zawertailo L; Persad D; Zack M; Busto UE
J Clin Psychopharmacol; 2013 Oct; 33(5):667-74. PubMed ID: 23963055
[TBL] [Abstract][Full Text] [Related]
15. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking.
Benowitz NL; Zevin S; Jacob P
Br J Clin Pharmacol; 1997 Mar; 43(3):259-67. PubMed ID: 9088580
[TBL] [Abstract][Full Text] [Related]
16. Intravenous and oral suicidal e-liquid poisonings with confirmed nicotine and cotinine concentrations.
Sommerfeld K; Łukasik-Głębocka M; Kulza M; Drużdż A; Panieński P; Florek E; Zielińska-Psuja B
Forensic Sci Int; 2016 May; 262():e15-20. PubMed ID: 27020616
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetic model of transdermal nicotine delivered from a matrix-type patch.
Linakis MW; Rower JE; Roberts JK; Miller EI; Wilkins DG; Sherwin CMT
Br J Clin Pharmacol; 2017 Dec; 83(12):2709-2717. PubMed ID: 28771779
[TBL] [Abstract][Full Text] [Related]
18. Death following intentional ingestion of e-liquid.
Chen BC; Bright SB; Trivedi AR; Valento M
Clin Toxicol (Phila); 2015 Nov; 53(9):914-6. PubMed ID: 26457570
[TBL] [Abstract][Full Text] [Related]
19. Transdermal nicotine inhibits interleukin 2 synthesis by mononuclear cells derived from healthy volunteers.
van Dijk AP; Meijssen MA; Brouwer AJ; Hop WC; van Bergeijk JD; Feyerabend C; Wilson JH; Zijlstra FJ
Eur J Clin Invest; 1998 Aug; 28(8):664-71. PubMed ID: 9767362
[TBL] [Abstract][Full Text] [Related]
20. Can transdermal nicotine patch cause acute intoxication in a child? A case report and review of literature.
Wain AA; Martin J
Ulster Med J; 2004 May; 73(1):65-6. PubMed ID: 15244132
[No Abstract] [Full Text] [Related]
[Next] [New Search]
